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We report here on a rare case of primary malignant melanoma of the female urethra. 
A 69-year-old female presented at our hospital with a several month history of dysuria, 
poor stream, gross hematuria, intermittent blood spots, and a painful mass at the ex-
ternal urethral meatus. The physical examination revealed a soft, small, chest-
nut-sized lesion through the urethral orifice. The mass was tan colored, ulcerated, cov-
ered with necrotic tissue, and protruded from the external urethral meatus. The mass 
was removed by wide local excision under spinal anesthesia. The pathological diagnosis 
was malignant melanoma of the urethra. Computed tomography of the abdomen as well 
as a whole-body bone scan showed no evidence of metastasis. The patient has been free 
of disease for 6 months postoperatively. We discuss the clinicopathologic features and 
treatment of this tumor.
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Primary malignant melanoma of the urethra in females is 
extremely rare and represents only 0.2% of all malignant 
melanomas [1]. To our knowledge, primary malignant mel-
anoma involving the urethra in females has been reported 
in only three cases in the Korean literature [2]. Most malig-
nant melanomas of the female urethra are located at the 
meatus or in the distal urethra [3]. The common pre-
sentations include bleeding, discharge, voiding dysfunc-
tion, or a mass [4]. Urethral melanomas are frequently mis-
diagnosed clinically, which leads to a delayed diagnosis, 
and patients with this tumor usually show a poor prognosis 
[4]. In this report, we present a case of melanoma originat-
ing from the urethra and we review the relevant medical 
literature.
CASE REPORT
A 69-year-old woman presented at our department with a 
several month history of dysuria, poor stream, gross hema-
turia, intermittent blood spots, and a painful mass at the 
external urethral meatus. She had no history of flank pain 
or passage of stones in the urine. She was postmenopausal 
and had no history of postmenopausal bleeding. She also 
had no history of hypertension, hyperlipidemia, diabetes, 
or pelvic surgery. The results of a chest X-ray and routine 
blood tests were normal at the presentation. The pelvic ex-
amination revealed a soft, chestnut-sized lesion protrud-
ing through the urethral orifice. The mass was tan colored, 
ulcerated, covered with necrotic tissue, and protruded from 
the external urethral meatus (Fig. 1). The findings of her 
speculum and vaginal examination of the cervix were 
unremarkable. The findings of her general physical exami-
nation were unremarkable. No organomegaly was found on 
an abdominal examination and no superficial lymph nodes 
were palpated. A cystourethroscopy was performed, which 
showed a polypoid, brownish growth involving only the ex-
ternal urethral meatus; there were no other abnormal find-
ings in the bladder.
The mass was removed by wide local excision with the 
patient under spinal anesthesia. Gross examination of the 
resected specimen revealed a polypoid solid mass (4.0x3.0x 
2.0 cm) with a dark-brown cut surface. The mass was cov-
ered with pinkish mucosa with surface ulceration. Micro-
scopic examination demonstrated large epithelioid tumor 
cells with dusty brown melanin pigments and frequent mi-
totic figures (Fig. 2). Immunohistochemical staining show-
ed that the malignant cells were immunoreactive for HMB- 
45 (Fig. 3A) and S-100 protein (Fig. 3B), which are sensitive Korean J Urol 2012;53:206-208
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FIG. 1. The appearance of the urethral malignant melanoma at 
presentation. There is a polypoid, tan colored, ulcerated mass of 
the external urethral meatus.
FIG. 2. Light microscopic findings of the surgical specimen. The 
large epithelioid tumor cells have dusty brown melanin pig-
ments and frequent mitotic figures are seen (H&E, x400).
FIG. 3. The immunohistochemical staining findings of the surgical specimen. The tumor cells were immunoreactive for HMB-45 (A) 
and S-100 protein (B).
markers for melanocyte differentiation. A macroscopically 
clean surgical margin was obtained. However, histology 
performed later revealed a microscopic positive margin. On 
the basis of these findings, the patient was diagnosed as 
having primary malignant melanoma of the urethra, stage 
T4bNxM0.
Abdominal computed tomography detected no lympha-
tic nodal swelling or distant metastases. The whole-body 
bone scan also revealed no evidence of metastasis. There 
was no evidence of any other primary tumor. We recom-
mended additional radical urethrectomy to obtain a wide 
enough surgical margin. However, the patient refused ad-
ditional surgery owing to her anxiety over losing a func-
tional organ. Although radiotherapy and chemotherapy 
were advised, she refused any further treatment. The pa-
tient is currently under close follow-up. Clinical and radio-
logical evaluations take place every 3 months. The patient 
has experienced no progression in disease, including sys-
temic metastasis, for more than 6 months as assessed by 
abdominal computed tomography and cystourethroscopy.
DISCUSSION
Malignant melanoma is one of the rarest tumors of the fe-
male urethra and usually originates from the distal ure-
thra [1]. It accounts for 0.2% of all malignant melanomas 
and 4% of all urethral cancers [3]. The first case of urethral 
melanoma was reported by Tyrell and Reed more than 100 
years ago [4,5]. A few additional cases have been reported Korean J Urol 2012;53:206-208
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since that time. Only five cases of urethral melanoma have 
been reported in the Korean literature, three in women and 
two in men [2].
Urethral malignant melanoma is three times as common 
in women as in men, like other malignant urethral tumors, 
and it is more frequent in the Caucasian population. Most 
cases are diagnosed after the fifth decade but some cases 
occur in younger patients [6,7]. The presenting symptoms 
include vaginal bleeding, mass, hematuria, and dysuria 
with a decreased urinary stream [8].
Microscopic examination of urethral malignant melano-
mas demonstrates a wide histologic spectrum with pat-
terns that include diffuse, nested, fascicular, and storiform 
growths of pleomorphic cells [4]. This variability has made 
immunohistochemical markers for melanocyte differ-
entiation a central part of making an accurate diagnosis. 
The most frequently used melanocytic markers in clinical 
practice are S-100 protein and HMB-45. Monoclonal anti-
body to S-100 protein is a sensitive marker that reacts with 
more than 90% of melanomas [9]. Although HMB-45 is 
quite specific for melanocytic neoplasms, it is less sensitive 
than S-100 protein for identifying melanoma [9]. In our 
case, as a result of this high sensitivity, the strong im-
munoreactivity to S-100 protein resulted in a diagnosis of 
malignant melanoma. Subsequent testing with HMB-45, 
a marker with higher specificity for melanocytic neo-
plasms, was conclusively positive and thus provided a de-
finitive diagnosis.
The urethral malignant melanoma has a worse prog-
nosis than a malignant melanoma of a cutaneous origin, 
partly because of the frequent finding of a vertical growth 
phase and lymph node metastasis at the time of initial diag-
nosis and partly because the location often results sig-
nificant delays in making the diagnosis [5]. Clinically, ure-
thral malignant melanomas are frequently polypoid and 
are usually mistaken for other malignant diseases or even 
benign lesions, including urethral polyps, caruncle, mu-
cosal prolapse, or chancre [4]. A few cases of urethral malig-
nant melanoma that were initially suspected to be urethral 
caruncle have been reported [10].
Primary malignant melanoma of the female urethra 
tends to metastasize at an early stage to adjacent areas, the 
regional lymph nodes, and occasionally distant sites by the 
hematogenous route. Therefore, in the case of malignant 
melanoma in the urethra, the treatment of choice is early 
extensive excision to control the local disease [2].
The treatment recommendations primarily depend on 
the tumor location and the clinical stage. The treatment 
varies from local excision with or without the addition of 
radiation therapy to extensive surgery, including cystour-
ethrectomy, vaginectomy, vulvectomy, and lymph node 
dissection [7]. Local excision, which should lead to good 
functional results, may be sufficient for relatively small, 
superficial, distal urethral tumors. However, local excision 
may not be adequate for good local control. A more ag-
gressive approach is needed for more proximal and ad-
vanced urethral tumors. In the present case, we performed 
wide local excision. In addition, we recommended addi-
tional radical urethrectomy with bladder preservation to 
obtain a wide enough surgical margin and to prevent the 
progression of the disease. However, when total urethrec-
tomy is done, patients must undergo urinary diversion, 
which requires an external appliance, and thus the pa-
tient's quality of life suffers. Ultimately, our patient re-
fused additional surgery because of anxiety over losing a 
functional organ.
The optimum treatment for urethral melanomas in 
women has not yet been defined. Several different surgical 
approaches were used in the cases with long-term survival 
that were described in the literature, but no definitive con-
clusions can be drawn because of the limited number of pa-
tients and the lack of information about the depth of in-
vasion in some of these cases [5]. Radical surgical resection 
with postoperative adjuvant chemotherapy or im-
munotherapy is recommended, but little clinical experi-
ence exists to support such adjuvant treatment. Occasional 
long-term survivors have been noted after radiation ther-
apy, and this suggests the potential role of postoperative 
radiation therapy to the tumor bed or to the regional lym-
phatics in high-risk patients [8].
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